GSK outlook brightens as Brexit brings currency windfall
 

GSK outlook brightens as Brexit brings currency windfall
LONDON (Reuters) - Demand for new medicines helped GlaxoSmithKline grow earnings in the second quarter and the drugmaker is set for big gains in the rest of 2016 thanks to a weak pound, after Britain's vote to leave the European Union.http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...18:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...18:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/FZILqaJeFYI